WBSI Guided Personalized Delivery of TTFields

NARecruitingINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
GBMGlioma Glioblastoma MultiformeTumor, Brain
Interventions
DIAGNOSTIC_TEST

Whole Brain Spectroscopy Imaging Array Mapping Layout

All study participants will receive whole brain spectroscopy imaging as a part of MRI study time points. Participants assigned to the advanced MR imaging array mapping layout study arm will receive tumor treating fields mapping from Optune that is created from the spectroscopy sequences or advanced MR imaging. Participants assigned to the conventional array mapping layout will still receive advanced imaging sequences or spectroscopy imaging at all time points.

Trial Locations (2)

19104

RECRUITING

Abramson Cancer Center, Philadelphia

RECRUITING

Penn Medicine, University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

NovoCure Ltd.

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER